Abstract
Objectives Fever is common among individuals seeking healthcare after traveling to tropical regions. Despite the association with potentially severe disease, the etiology is often not determined. Cytokines are soluble mediators dynamically regulated in the response to infection. Measuring cytokines in the blood can therefore be informative to understanding the host-response to infection and can potentially indicate the type of pathogen that causes the disease.
Method In this study, we measured 49 host-response proteins in the plasma of 124 patients with fever after travel to tropical or subtropical regions. The patients had confirmed diagnosis of either malaria, dengue fever, influenza, bacterial respiratory tract infection, or bacterial gastroenteritis, representing the most common disease etiologies. We used multivariate and machine learning methods to assess host-response protein profiles between the different disease groups and healthy control subjects with the aim of identifying disease-associated protein signatures.
Results The host-response varied between disease groups and different combinations of proteins contributed to distinguishing infected patients from healthy controls, and from each other. Malaria displayed the most unique protein signature, indicating a strong immunoregulatory response with high levels of IL10, sTNFRI and II, and sCD25 but low levels of sCD40L. In contrast, bacterial gastroenteritis had high levels of sCD40L, APRIL, and IFN-γ, while dengue was the only infection with elevated IFNα2.
Conclusions These results suggest that characterization of the inflammatory profile of individuals with fever can help to identify disease-specific host responses, which in turn can be used to guide future research on diagnostic strategies and adjuvant treatment.
Author summary Upon infection with a pathogen, the host’s immune system will sense the infection and initiate an immune response. Depending on the type of pathogen and the cells that sense it, the resulting immune response will be different. Fever is a common symptom of infection and it is often difficult to identify the specific pathogen responsible for the disease. In this study, we aimed to characterise and compare circulating inflammation-associated proteins elicited in response to the most common pathogens leading to fever after travel to tropical or subtropical areas. The pathogens included viruses, bacteria, and parasites. Based on the protein signatures, we could observe both disease-general patterns (upregulated in all disease groups) and disease-specific patterns (associated with specific diseases). Malaria displayed the most unique signature and was associated with the upregulation of several immunoregulatory proteins. Possibly in response to a pro-inflammatory response. Dengue fever was also associated with a mix of pro- and anti-inflammatory proteins, while bacterial gastroenteritis had a mainly pro-inflammatory profile. Comparing the protein profiles between diseases indicated unique patterns that could potentially be further developed for clinical use.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by funding from the Magnus Bergvall Foundation (2018-02656), Tore Nilsson Foundation (2018-00608), Swedish Society of Medicine (SLS-934363), Åke Wiberg Foundation (M18-0076), the Swedish Heart-Lung Foundation (20220566) and the Swedish Research Council (2019-01940 and 2021-03706) to CS and grants from Tornspiran foundation to KS and ALF-grants from Region Stockholm to AF. Work with JG was supported by grants from the Swedish Heart-Lung Foundation (20190478), the Swedish Research Council (2019-01034), the Regional Agreement on Medical Training and Clinical Research between Stockholm County Council, and the Karolinska Institutet (20180120).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Swedish Ethical Review Authority (2006/893-31/4 with addendums 2018/2354-32 and 2019-03436). The study was approved by the Swedish Ethical Review Authority (2016/2512-31/2).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
First and last author have changed order. Some analysis and text have been added and the discussion has been changed according to suggestions from reviewers. The ms was however rejected and these changes were made to the version now submitted to another journal.
Data availability statement
The data will be available upon reasonable request to the corresponding author.